Biotech Startups

Theriva Biologics is a clinical-stage company developing therapeutics for cancer and related diseases, including an oncolytic adenovirus platform (VCN-01) and enzyme-based candidates for gastrointestinal and systemic conditions (SYN-004, SYN-020). It is a publicly traded biopharmaceutical company (NYSE American: TOVX) focused on areas of high unmet medical need.

1 investor

Therna develops an AI platform that designs and optimizes programmable RNA medicines, including mRNA and antisense oligonucleotide/siRNA therapeutics, using generative AI models informed by proprietary experimental validation data.

1 investor

Theseus Labs develops brain-computer interfaces and publishes neurotechnology research, while building software products for BCI data calibration and neuro-applications. The company also invests in and supports early-stage neurotech startups.

1 investor

Thestra is a University of Turku spin-out developing AI-based cancer diagnostics, including its EPLINEX biomarker assay that estimates tumor aggressiveness in head and neck squamous cell carcinoma (HNSCC) to help clinicians stratify patients to appropriate therapies. Its products serve clinicians and hospitals to guide treatment selection and prognosis.

1 investor

ThirtyFiveBio is a drug discovery company developing GPR35 antagonists to treat gastrointestinal diseases, with a focus on ulcerative colitis by targeting epithelial dysfunction. Founded in 2021, it operates as part of the Molecule to Medicine ecosystem and is advancing preclinical candidates toward first-in-human trials.

1 investor

Thoracic Innovations is a medical device company that develops products using computer-aided design, rapid prototyping, and 3D printing, with a focus on the cardiothoracic and thoracic clinical area.

1 investor

Thornhill Therapeutics is a biologics company focused on developing therapeutics.

1 investor

Those Vegan Cowboys produces animal-free casein and other milk proteins through precision fermentation, using a technology platform to design proteins with specific functionality such as stretch, melt, and foaming for cheese and dairy alternatives. It works with cheese makers, food companies, farmers, and chefs serving the food industry.

1 investor

Thrive Bioscience develops the Thrive IQ software platform and CellAssist imaging systems that capture and analyze time-series morphological data on live cells, colonies, and organoids in culture. Its products produce ML/AI-ready phenotypic data sets for biologists and data scientists working in cell biology and bioprocessing.

1 investor

Thryv Therapeutics is a clinical-stage biotech developing precision-medicine treatments for genetic arrhythmia syndromes and acquired cardiometabolic diseases using selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1). It is running a clinical study (Wave II) for people with Long QT Syndrome Type 2.

1 investor

Thunder Biotech is a cancer immunotherapy company developing MOTO-CAR treatments, which genetically engineer a patient's own macrophages into chimeric antigen receptor cells that target biomarkers on tumor cells to attack solid tumors. It focuses on immunotherapy for cancer patients with solid tumors.

1 investor

Thyreos develops recombinant herpesvirus-based vaccines for both animal and human health applications, designed to generate immune responses without affecting the nervous system. The company's platform targets herpesviruses that cause latent nervous system infections.

1 investor

A clinical-stage biotech company developing tissue-protective therapeutics, specifically focused on the drug Tiprelestat to prevent inflammatory organ damage in patients undergoing major surgery.

1 investor

Tiger Lifescience develops medical devices using platform technology to prevent hospital-acquired infections across applications including catheter care, surgical sites, and hemodialysis. The company targets hospitals and healthcare providers managing infectious disease complications in clinical settings.

1 investor

TileBio develops self-supervised AI foundation models for digital pathology, applied to cancer diagnosis, prognosis, biomarker discovery, and drug development. It serves clinicians, diagnostics, and pharmaceutical research by analysing pathology imaging and sequencing data.

1 investor

Timberlyne Therapeutics is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases by acquiring drug assets against validated targets. Its lead program, CM313, is a CD38-targeting monoclonal antibody being tested across conditions including immune thrombocytopenia, systemic lupus erythematosus, and multiple myeloma.

1 investor

Time BioVentures is a venture capital firm that invests in life sciences and healthcare startups developing new medical and biotech technologies. It is based in Southern California.

1 investor

Tinker Bio (霆科生物) develops microfluidics-based laboratory instruments, including an organ-on-a-chip culture and fluid control system (MOI-200), an automated microfluidic droplet generation system (DPS-300PRO), and a high-throughput microsphere preparation system (MSF-100). Its products serve life science research, drug screening, and clinical translation applications.

1 investor

Tinkeso Therapeutics (formerly Akeso Therapeutics) is an early-stage biotech company developing off-the-shelf, allogeneic Natural Killer T (NKT) cell therapies to treat cancers and other immune-mediated disorders. Its pipeline includes native and engineered NKT cell therapies, with a lead engineered invariant NKT (iNKT) cell therapy targeting several types of leukemia.

1 investor

Tint operates an algae biorefinery that processes spirulina biomass into natural food and beverage colors, supplement actives, cosmetic actives, and an agricultural biostimulant. It serves food, supplement, cosmetics, and agriculture companies with ingredients stable enough to survive manufacturing and shelf life, with entities and plants in Spain and India.

1 investor

HaloMicroscopy develops laser-free, label-free optical imaging instruments that capture live cells, tissues, and materials in air or liquid without sample prep or fluorescent tags. Its plug-and-play HaloElement instrument delivers multi-scale, real-time imaging from nanometres to millimetres for industry, research labs, and imaging core facilities.

1 investor

Tiny Technologies develops liquid premium dietary supplements using its TINYsphere technology platform, which encapsulates nutrients in liquid microcapsules (liposomes, nanoemulsions, and micelles) to improve bioavailability and absorption via the oral mucosa. The company works with brands and business partners as a B2B supplement formulation and manufacturing provider based in Germany.

1 investor

The Tiny Cargo Co. isolates milk-derived exosomes from cow's milk at industrial scale and loads them with therapeutic cargoes such as peptides, RNAs, and biologics for oral drug delivery. It serves pharmaceutical partners developing therapeutics and is advancing XOlacta, a milk-exosome drug loaded with the aCT11 peptide as a cardioprotectant and radioprotectant.

1 investor

Tissue Dynamics operates a drug discovery platform that uses real-time sensors, robotic automation, and AI software to grow and monitor human organoids at scale, generating human-relevant data on drug safety, efficacy, and toxicity. It serves pharmaceutical and biotech partners with compound profiling, screening, and target identification to de-risk and accelerate drug development.

1 investor